For: | Mohamed EA, Giama NH, Abdalla AO, Shaleh HM, Oseini AM, Ali HA, Ahmed F, Taha W, Ahmed Mohammed H, Cvinar J, Waaeys IA, Ali H, Allotey LK, Ali AO, Mohamed SA, Harmsen WS, Ahmmad EM, Bajwa NA, Afgarshe MD, Shire AM, Balls-Berry JE, Roberts LR. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence. World J Gastroenterol 2022; 28(35): 5217-5229 [PMID: 36188718 DOI: 10.3748/wjg.v28.i35.5217] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i35/5217.htm |
Number | Citing Articles |
1 |
Shuomin Wang, Mingran Zhou, Yunhong Xia. COL15A1 interacts with P4HB to regulate the growth and malignancy of HepG2.2.15 cells. Biochemical and Biophysical Research Communications 2023; 681: 20 doi: 10.1016/j.bbrc.2023.09.031
|
2 |
Tuong-Anh Mai-Phan, Trong-Kha Nguyen, Tri-Nhan Pham, Minh-Quang Tran, Kim-Long Le. Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study. World Journal of Hepatology 2025; 17(5): 104041 doi: 10.4254/wjh.v17.i5.104041
Abstract(87) |
Core Tip(80) |
Full Article(HTML)(444)
|
Full Article with Cover (PDF)-18015K(18)
|
Audio-378K(2)
|
Peer-Review Report-233K(16)
|
Answering Reviewers-83K(11)
|
Supplementary Material-51K(10)
|
Full Article (PDF)-17624K(26)
|
Full Article (XML)-161K(14)
|
Times Cited (0)
|
Total Visits (1071)
|
Open
|
3 |
Youwen Du, Linxin Pan, Wenchen Zhang, Shuangbiao Wei, Xu Fan, Na Zhang, Pengjun Wei, Xiaoqian Chen, Zhi Qiao, Li Xie. CNDP1 Suppresses the Malignant Behavior of Hepatoma Cell via Restricting PI3K-AKT-mTOR Activation. Current Cancer Drug Targets 2025; 25(2): 131 doi: 10.2174/0115680096332450240827070033
|
4 |
Chao Lin, Jiacheng Wu, Zhixuan Wang, Yien Xiang. Long non-coding RNA LNC-POTEM-4 promotes HCC progression via the LNC-POTEM-4/miR-149-5p/Wnt4 signaling axis. Cellular Signalling 2024; 124: 111412 doi: 10.1016/j.cellsig.2024.111412
|